The COVID-19 vaccine Pfizer produced with BioNTech is 100 per cent effective in children aged 12 to 15, according to a press release from the pharmaceutical giant. As Eric Sorensen explains, while no shot has been approved for use for this age bracket yet, the preliminary results of the clinical trial are raising hopes for the future.
- Pfizer asks European Union to approve vaccine for kids aged 12 to 15
- Pfizer-BioNTech could test vaccine on kids as young as 6 months by September
- Israel examining cases of heart inflammation in people who received Pfizer COVID-19 shot